Drug firm partnerships, outsourcing will be necessary, study says

02/6/2008 | American City Business Journals

Drugmakers are more likely to benefit in the long run from partnerships and outsourcing rather than relying solely on in-house research and development, according to a report by the Tufts Center for the Study of Drug Development. "Moving forward, no company -- big, medium or small pharma, or biotech -- will develop new drugs entirely alone," Kenneth Kaitin, director of the Tufts Center.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD